Gulsen Kama - Jun 3, 2024 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Role: Chief Financial Officer
Signature: /s/ Jonathan V. Dixon, Attorney-in-Fact
Stock symbol: BNGO
Transactions as of: Jun 3, 2024
Transactions value $: $0
Form type: 4
Date filed: 6/5/2024, 05:48 PM
Previous filing: Sep 20, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BNGO	Common Stock	Award	$0	+16K		$0.00	16K	Jun 3, 2024	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BNGO	Stock Option (Right to Buy)	Award	$0	+75K		$0.00	75K	Jun 3, 2024	Common Stock	75K	$0.93	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan.
F2	The shares subject to the RSUs vest 1/4th annually beginning on the one-year anniversary of the grant date.
F3	The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of June 3, 2024 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date.